KRONOX Lab Sciences Limited has intimated both National Stock Exchange of India Limited and BSE Limited about an upcoming Board of Directors meeting scheduled for Wednesday, August 12, 2026.
The primary agenda for the board meeting is to consider and approve the Unaudited Standalone Financial Results for the quarter ended June 30, 2026 (Q1 FY27).
The company has confirmed that the Trading Window for trading in the company's securities remains closed for Directors, Officers, and designated employees of the Company. The closure period began on July 1, 2026 and will continue until 48 hours after the declaration of the Unaudited Standalone Financial Results for the quarter ended June 30, 2026.